Dual bronchodilation vs triple therapy in the real-life DACCORD study

C. Criee (Bovenden, Germany), P. Kardos (Frankfurt, Germany), H. Worth (Fuerth, Germany), N. Lossi (Nuernberg, Germany), K. Kostikas (Basel , Switzerland), C. Vogelmeier (Marburg, Germany), R. Buhl (Mainz, Germany)

Source: International Congress 2018 – Innovative therapies in asthma and COPD
Session: Innovative therapies in asthma and COPD
Session type: Poster Discussion
Number: 611
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Criee (Bovenden, Germany), P. Kardos (Frankfurt, Germany), H. Worth (Fuerth, Germany), N. Lossi (Nuernberg, Germany), K. Kostikas (Basel , Switzerland), C. Vogelmeier (Marburg, Germany), R. Buhl (Mainz, Germany). Dual bronchodilation vs triple therapy in the real-life DACCORD study. 611

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: